MedPath

Serum leptin and lipid profile before and after Omega-3 supplementation fatty acid in neonates with IUGR

Phase 3
Conditions
Health Condition 1: P059- Newborn affected by slow intrauterine growth, unspecifiedHealth Condition 2: P051- Newborn small for gestational age
Registration Number
CTRI/2024/07/069980
Lead Sponsor
Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences,Rohtak
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Full Term Neonate between thirty seven weeks to fourty one plus six weeks

SGA

Ponderal index less than two

On full feeds

Exclusion Criteria

Preterm neonates

Neonates who died before feeding is established

neonates with congenital infection, with multiple congenital anomalies/malformation

Neonates with Cholestasis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
effects of Omega-3 fatty acid supplementation on serum leptin levels of IUGR neonatesTimepoint: At enrollment and at 4 week of supplementation
Secondary Outcome Measures
NameTimeMethod
effects of omega 3 fatty acid supplementation on lipid profile and on anthropomertic measurementsTimepoint: lipid profile: at enrollment and after 4 weeks <br/ ><br>anthropometry: daily,weekly according to criteria
© Copyright 2025. All Rights Reserved by MedPath